Both in Pharmaceuticals
Vertex Pharmaceuticals vs Merck & Co.
Over the past year VRTX returned +31.2% and MRK returned +81.3%; their daily moves had a correlation of 0.42.
VRTX +31.2% MRK +81.3%Growth of $1, one year, split-adjusted
| Metric | VRTX | MRK |
|---|---|---|
| Price | $558.88 | $149.52 |
| Market cap | $141.65B | $368.89B |
| Today | +3.50% | +2.18% |
| 1 month | +10.3% | +4.0% |
| 6 months | +31.8% | +33.3% |
| Year to date | +23.3% | +42.0% |
| 1 year | +34.0% | +72.7% |
| Revenue growth (YoY) | +12.5% | +5.1% |
| Gross margin | 85.3% | 73.5% |
| Net margin | 33.0% | −8.0% |
| P/E (TTM) | 32.2× | 116.3× |
| Price / sales | 11.3× | 5.5× |
| Net cash | $7.85B | -$46.77B |
| Dividend yield | — | 2.27% |
| Volatility (60d) | 28.7% | 36.0% |
| Short % of float | 1.7% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).